About InterShunt Technologies
InterShunt Technologies is a company based in United States founded in 2015 by Gil Vardi. InterShunt Technologies has raised $26.55 million across 3 funding rounds from investors including Gener8tor, Solas BioVentures and Arsenal Capital Management. InterShunt Technologies offers products and services including PAS-C. InterShunt Technologies operates in a competitive market with competitors including Silk Road Medical, Lifetech Scientific Corporation, HDL Therapeutics, Supira Medical and Transvascular, among others.
- Headquarter Louisiana, United States
- Founders Gil Vardi
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Intershunt Technologies, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$26.55 M (USD)
in 3 rounds
-
Latest Funding Round
$23.42 M (USD), Series B
Aug 09, 2024
-
Investors
Gener8tor
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of InterShunt Technologies
InterShunt Technologies offers a comprehensive portfolio of products and services, including PAS-C.
Catheter system to create atrial shunts for heart failure relief.
People of InterShunt Technologies
Unlock access to complete
Unlock access to complete
Funding Insights of InterShunt Technologies
InterShunt Technologies has successfully raised a total of $26.55M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $23.42 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in InterShunt Technologies
InterShunt Technologies has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Gener8tor, Solas BioVentures and Arsenal Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Venture capital and acceleration are provided to life science startups.
|
Locked | Locked | Locked |
Investor details for InterShunt Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by InterShunt Technologies
Investment portfolio details for InterShunt Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - InterShunt Technologies
Detailed financials for InterShunt Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Intershunt Technologies Comparisons
Peer comparison for InterShunt Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of InterShunt Technologies
InterShunt Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Silk Road Medical, Lifetech Scientific Corporation, HDL Therapeutics, Supira Medical and Transvascular, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of neuroprotection devices for carotid artery disease
|
|
| Locked | Locked | Locked |
Interventional devices for cardiovascular and vascular diseases are developed.
|
|
| Locked | Locked | Locked |
Therapy to reverse coronary atherosclerosis is developed using patient plasma.
|
|
| Locked | Locked | Locked |
Developer of ventricular assist devices for coronary intervention and cardiogenic shock
|
|
| Locked | Locked | Locked |
A TransAccess Catheter System that is used to deliver cells to damaged portions of the heart
|
|
| Locked | Locked | Locked |
Catheter ablation treatments for atrial fibrillation are developed.
|
Detailed competitors of InterShunt Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Intershunt Technologies
Complete news archive for InterShunt Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about InterShunt Technologies
InterShunt Technologies was founded in 2015 and raised its 1st funding round 3 years after it was founded.
InterShunt Technologies is headquartered in United States. It is registered at Louisiana, United States.
Harlee Sorkin is the current CEO of InterShunt Technologies.
InterShunt Technologies is a funded company, having raised a total of $26.55M across 3 funding rounds to date.
InterShunt Technologies was founded in 2015 and is based in Louisiana, United States. Focus is placed on the medical device sector, where cardiac catheters are developed for treating cardiac conditions. Operations center on the creation of intershunt atrial septostomy catheters, which facilitate precise tissue capture, cutting, and excision from the interatrial septum. This approach aids in lowering elevated left atrial pressure. The domain intershunt.com is utilized for online presence.
InterShunt Technologies's top competitors include Silk Road Medical, Lifetech Scientific Corporation and Supira Medical.
InterShunt Technologies offers PAS-C.
InterShunt Technologies has 4 investors. Key investors include Gener8tor, Solas BioVentures, Arsenal Capital Management, and BioGenerator Ventures.